173 related articles for article (PubMed ID: 71601)
21. [Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
Di Perri T; Forconi S; Guerrini M; Rossi C; Pecchi S
Boll Soc Ital Cardiol; 1977; 22(7):1138-50. PubMed ID: 618247
[No Abstract] [Full Text] [Related]
22. Early rheological and microcirculatory changes in children with type I diabetes mellitus.
Koscielny J; Latza R; Wolf S; Kiesewetter H; Jung F
Clin Hemorheol Microcirc; 1998 Oct; 19(2):139-50. PubMed ID: 9849927
[TBL] [Abstract][Full Text] [Related]
23. [Biorheological views of diabetic macroangiopathy].
Uchimura I
Nihon Rinsho; 2006 Nov; 64(11):2159-63. PubMed ID: 17087312
[TBL] [Abstract][Full Text] [Related]
24. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
Barras JP; Michal M
Vasa; 1986; 15(3):200-5. PubMed ID: 3532608
[No Abstract] [Full Text] [Related]
25. Erythropoietin in diabetic macular edema and renal insufficiency.
Friedman EA; Brown CD; Berman DH
Am J Kidney Dis; 1995 Jul; 26(1):202-8. PubMed ID: 7611253
[TBL] [Abstract][Full Text] [Related]
26. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
27. The therapeutic effect of lipo PGE1 on diabetic neuropathy-changes in endothelin and various angiopathic factors.
Itoh Y; Yasui T; Kakizawa H; Makino M; Fujiwara K; Kato T; Imamura S; Yamamoto K; Hishida H; Nakai A; Itoh M; Nagasaka A
Prostaglandins Other Lipid Mediat; 2001 Oct; 66(3):221-34. PubMed ID: 11577785
[TBL] [Abstract][Full Text] [Related]
28. [Erythrocyte aggregation in vivo and diabetic microangiopathy. Physiopathologic determinants and clinical correlations].
Benhamou PY; Carpentier P; Halimi S; Bertrand C; Mouillon M; Franco A
Diabete Metab; 1990; 16(3):192-8. PubMed ID: 2210013
[TBL] [Abstract][Full Text] [Related]
29. C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome.
Mavrakanas T; Frachebois C; Soualah A; Aloui F; Julier I; Bastide D
Presse Med; 2009 Oct; 38(10):1399-403. PubMed ID: 19419831
[TBL] [Abstract][Full Text] [Related]
30. Increased platelet aggregation in diabetes mellitus.
Kwaan HC; Colwell JA; Cruz S; Suwanwela N; Dobbie JG
J Lab Clin Med; 1972 Aug; 80(2):236-46. PubMed ID: 5044780
[No Abstract] [Full Text] [Related]
31. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
[TBL] [Abstract][Full Text] [Related]
32. Retinopathy, neuropathy and nephropathy in non-insulin-dependent diabetic patients.
Tai TY; Tseng CH; Sung SM; Huang RF; Chen CZ; Tsai SH
J Formos Med Assoc; 1991 Oct; 90(10):936-40. PubMed ID: 1685173
[TBL] [Abstract][Full Text] [Related]
33. [Hyperglycemia as a cause of diabetic complications].
Wieland OH
Verh Dtsch Ges Inn Med; 1987; 93():187-93. PubMed ID: 3442101
[No Abstract] [Full Text] [Related]
34. Diabetes mellitus: can we reduce the complications?
Malins JM
J R Coll Physicians Lond; 1976 Apr; 10(3):289-93. PubMed ID: 1263165
[No Abstract] [Full Text] [Related]
35. Prevalence of overt diabetic nephropathy in patients with noninsulin-dependent diabetes mellitus.
Norymberg C; Shenkman L
Isr J Med Sci; 1991 Mar; 27(3):124-30. PubMed ID: 2016150
[TBL] [Abstract][Full Text] [Related]
36. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.
Looker HC; Fagot-Campagna A; Gunter EW; Pfeiffer CM; Narayan KM; Knowler WC; Hanson RL
Diabetologia; 2003 Jun; 46(6):766-72. PubMed ID: 12774164
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of various hemorheologic parameters in diabetes mellitus].
Cella A; Bianchi E; Reali GL; Piana A; Armani U
Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
[TBL] [Abstract][Full Text] [Related]
38. Interrelationships of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: a multinational study.
West KM; Ahuja MM; Bennett PH; Grab B; Grabauskas V; Mateo-de-Acosta O; Fuller JH; Jarrett RJ; Keen H; Kosaka K; Krolewski AS; Miki E; Schliack V; Teuscher A
Diabetologia; 1982 Jun; 22(6):412-20. PubMed ID: 7049799
[TBL] [Abstract][Full Text] [Related]
39. Role of plasma ascorbate in diabetic microangiopathy.
Ali SM; Chakraborty SK
Bangladesh Med Res Counc Bull; 1989 Dec; 15(2):47-59. PubMed ID: 2629696
[TBL] [Abstract][Full Text] [Related]
40. Association between serum magnesium and common complications of diabetes mellitus.
Zhang Y; Li Q; Xin Y; Lv W; Ge C
Technol Health Care; 2018; 26(S1):379-387. PubMed ID: 29758962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
